Melanoma

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) IND.224A Phase II Study of Concurrent Dabrafenib and Trametinib with Stereotactic Radiation in the Management of Patients with BRAF Mutation-Positive Malignant Melanoma and Brain MetastasesMcWhirter, Dr ElaineOpen to recruitmentNCT02974803
(CCTG) ME.13/STOP-GAPA Randomized Phase III Study of Duration of Anti-PD-1 Therapy in Metastatic Melanoma (STOP-GAP)McWhirter, Dr ElaineOpen to recruitmentNCT02821013
(Novartis) CDRB436F2410COMBI-APlus: Open-label, phase IIIb study to evaluate the impact on pyrexia related outcomes of an adapted pyrexia AE-management algorithm (Plus) with dabrafenib in COMBInation with trametinib in the Adjuvant treatment of high-risk stage III BRAF V600 mutation-positive melanoma after complete resectionMcWhirter, Dr ElaineOpen to recruitmentNCT03551626
Download PDF